EndoChoice is a company that provides devices, diagnostics and procedural support for specialists treating gastrointestinal diseases. This expansion marks the third time in two years that the company has increased its square footage to keep up with growth.
In mid-2010, EndoChoice relocated to its existing facility, more than doubling its previous space. The move provided more space for a state-of-the-art GI anatomic pathology laboratory, which is a national reference laboratory accredited by the College of American Pathologists.
The latest expansion will increase the company’s space from 35,000 to 60,000 square feet. The new space will accommodate automation and process flow improvements in the production, controlled environment and warehouse areas.
Related Articles on EndoChoice:
EndoChoice to Receive Georgia Bio Deal of the Year Award
EndoChoice Enters Into Agreement With Premier Healthcare Alliance
EndoChoice Purchases Atlanta Pathology Lab
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.